{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:35Z","timestamp":1786119275701,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/ico.0b013e31818d382d","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T08:04:26Z","timestamp":1242893066000},"page":"468-470","source":"Crossref","is-referenced-by-count":36,"title":["Effect of Subconjunctival Bevacizumab on Primary Pterygium"],"prefix":"10.1097","volume":"28","author":[{"given":"Christopher C","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandesh N","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210227","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00055735-199908000-00011","article-title":"The pathogenesis of pterygia.","volume":"10","author":"Coroneo","year":"1999","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-20-20210227","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/bjo.67.9.604","article-title":"Histology of pterygium: an electron microscopic study.","volume":"67","author":"Cameron","year":"1983","journal-title":"Br J Ophthalmol"},{"key":"R3-20-20210227","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/eye.1989.31","article-title":"Pathogenesis of pterygium.","volume":"3","author":"Hill","year":"1989","journal-title":"Eye"},{"key":"R4-20-20210227","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00003226-200307000-00015","article-title":"Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia.","volume":"22","author":"Jin","year":"2003","journal-title":"Cornea"},{"key":"R5-20-20210227","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/00003226-200110000-00013","article-title":"Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia.","volume":"20","author":"Lee","year":"2001","journal-title":"Cornea"},{"key":"R6-20-20210227","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.mehy.2007.01.047","article-title":"Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia.","volume":"69","author":"Hosseini","year":"2007","journal-title":"Med Hypotheses"},{"key":"R7-20-20210227","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1167\/iovs.06-1149","article-title":"Prognosis-determinant candidate genes identified by whole genome scanning in eyes with pterygia.","volume":"48","author":"Kuo","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-20-20210227","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0065-1281(96)80038-9","article-title":"Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor, and tumor necrosis factor in primary pterygium.","volume":"98","author":"Kria","year":"1996","journal-title":"Acta Histochem"},{"key":"R9-20-20210227","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s004170050144","article-title":"Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis.","volume":"236","author":"Kria","year":"1998","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R10-20-20210227","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ophtha.2005.01.023","article-title":"Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.","volume":"112","author":"Gebhardt","year":"2005","journal-title":"Ophthalmology"},{"key":"R11-20-20210227","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.eye.6702495","article-title":"Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1.","volume":"21","author":"Aspiotis","year":"2007","journal-title":"Eye"},{"key":"R12-20-20210227","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ajo.2006.05.061","article-title":"Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases.","volume":"142","author":"Kaiser","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R13-20-20210227","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/bjo.2003.039891","article-title":"Mitomycin C for pterygium: long term evaluation.","volume":"88","author":"Raiskup","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R14-20-20210227","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1097-0347(200003)22:2<183::AID-HED11>3.0.CO;2-R","article-title":"Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer.","volume":"22","author":"Riedel","year":"2000","journal-title":"Head Neck"},{"key":"R15-20-20210227","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0008-4182(05)80031-6","article-title":"Treatment of early pterygium recurrence with topical administration of interferon alpha-2b.","volume":"40","author":"Esquenazi","year":"2005","journal-title":"Can J Ophthalmol"},{"key":"R16-20-20210227","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02713680701799101","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.","volume":"33","author":"Bahar","year":"2008","journal-title":"Curr Eye Res"},{"key":"R17-20-20210227","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archopht.125.6.834","article-title":"Topical bevacizumab therapy for corneal neovascularization.","volume":"125","author":"DeStafeno","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R18-20-20210227","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization.","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"key":"R19-20-20210227","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization.","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-200905000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:53:10Z","timestamp":1786038790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-200905000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31818d382d","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}